Bringingtomorrows ofhope  
 

BTF is a critical lifeline for those who suffer from brain tumors.

Our Mission

greybarThe Brain Tumor Foundation supports the whole patient by addressing their social, financial and emotional needs.

BTF raises awareness among medical professionals and the public about the need for the early detection of brain tumors while continuing to offer support groups, medical referrals, and informational events. The Foundation’s expertise, compassion and resources ensure that brain tumor patients have a powerful ally in their fight against this disease.

Founded in 1998 by Dr. Patrick J. Kelly, the Brain Tumor Foundation (BTF) guides and supports patients and families during the turbulent times when their lives are touched by a brain tumor.

The Road to Early Detection Campaign, an initiative of the Brain Tumor Foundation, was launched to promote the early detection of brain tumors and brain scan screenings. The initial pilot program reached out to communities – particularly those under-served in the five boroughs of New York City.

Based on New York’s success, the Brain Tumor Foundation launched the National Sponsor-A-City Tour component beginning with Boston, continuing on to Philadelphia, New York, and Las Vegas. Additional cities are scheduled to be visited in the coming months.

In collaboration with a multi-disciplinary research team at Columbia University and the Mailman School for Public Health — comprised of experts in oncology, cancer epidemiology, neuroradiology, neurosurgery and neurology — BTF is gathering key information to help us better understand the relationship between patient factors and brain tumors.

Although MRI screening for brain tumors is not considered part of standard preventive care, we hope that our research examining the brain scans of thousands of individuals around the country will shed new light on brain tumors allowing for more effective treatment options and the prevention of this dreaded disease.

Number of people in the United States

diagnosed with a brain or central nervous system tumor this year

Your Support Team

brain tumor quoteCatching brain tumors when they are small gives many more options. Over half of all brain tumor patients could have their tumors successfully removed if detected early, before symptoms become apparent. The only way to detect a tumor early is with an MRI brain scan.– Dr. Patrick J. Kelly

The Brain Tumor Foundation offers patients information on treatment options and referrals to appropriate clinical trials or brain tumor centers throughout the country.

The Foundation works in association with patient, caregiver and family support groups nationwide, as well as with doctors and researchers at the forefront of finding the best and most effective treatments for brain tumors.

BTF also produces informational events and utilizes social media outlets to dispense important medical updates, brain tumor news and alerts to patients and their families.

BTF President Philip E. Stieg, PhD, MD

BTF President Philip E. Stieg, PhD, MD

Close to 700,000 people in the US will be diagnosed with a primary or metastatic brain tumor. That’s a huge patient population. It’s the equivalent of breast cancer, and more than Parkinson’s and Alzheimer’s. All of these diseases are receiving an incredible amount of public attention. It is our goal at the Brain Tumor Foundation to get the word out about the prevalence of this devastating disease.

– Dr. Philip E. Stieg

Dr. Philip E. Stieg, world-renowned neurosurgeon and neuroscientist is the Foundation’s President.

Dr. Stieg is Chairman of Weill Cornell Medical College Department of Neurological Surgery, Neurosurgeon-in-Chief at New York Presbyterian/Weill Cornell Medical Center and Chairman and Founder of the Weill Cornell Brain and Spine Center, which is the leading neuroscience patient care center in New York City. He is a widely published author and internationally known lecturer, and for more than 20 years has been consistently named one of the nation’s Top Doctors by Castle Connolly.

New York City’s interdisciplinary neuroscience patient care center for the comprehensive treatment of Central Nervous System diseases was founded by Dr. Stieg. The Center’s research program enrolls thousands of patients in clinical trials for novel treatments ranging from degenerative lumbar disc and cognitive impairment to Parkinson’s, Brain Tumors and Epilepsy utilizing the latest therapies in precision medicine. In 2014, he launched the first neuromedical-staffed Concussion Center in New York.

Dr. Stieg also serves as a sideline consultant for the National Football League and a consulting neurosurgeon to the New York Giants, as well as an advisor to the Department of Defense on traumatic brain injury in the military.

brain tumor quoteWe routinely check for lung, breast, colon, prostate and other cancers – why not brain tumors? Early detection is the best insurance that treatment will be effective and more lives will be saved.-Michael Schreiber

BTF Chairman Michael Schreiber

Michael Schreiber became determined to help brain tumor patients and their families after living through his own father’s battle with a brain tumor. He has been actively involved in all aspects of BTF since its inception in 1998.

An influential business and community leader, Michael is President of Royal Farms, a privately owned real estate management firm. Under his leadership BTF has created and implemented many innovative programs including the unprecedented Road to Early Detection initiative, and most recently, the national expansion of that campaign, Sponsor-A-City.

Founding President Patrick J. Kelly, M.D., F.A.C.S.

Dr. Patrick J. Kelly is the retired Joseph Ransohoff Professor of Neurosurgery at NYU School of Medicine. Dr. Kelly is an internationally recognized authority on brain tumor surgery, and a pioneer in stereotactic neurosurgery and computer application in neurosurgery.

Over his long career he has operated on more than 7,500 brain tumors and has seen firsthand the devastation these malignancies – almost always caught too late for effective treatment – can inflict on patients and loved ones. Dr. Kelly is a recipient of the Karolinska Institute’s prestigious Olivecrona Prize, the World Federation of Neurological Societies’ Scoville Achievement Award and the Irish Sir Peter Freyer Medal. Dr. Kelly is past President of the American Society of Stereotactic and Functional Neurosurgery, was Vice President of the World Society of Stereotactic Functional Neurosurgery and a Member of the Medical Advisory Council of the Association for Brain Tumor Research. He has authored more than 230 scientific and clinical papers and book chapters and served on the editorial boards of Neurosurgery, Surgical Neurology, Journal of Stereotactic and Functional Neurosurgery and Neurological Research.

In 1998 Dr. Kelly helped give a focus and voice to the fight against brain cancer by forming the nonprofit Brain Tumor Foundation. He was also the visionary behind the Road to Early Detection campaign, through which BTF has worked to educate medical professionals and the public about the need for the early detection of brain tumors.

Board of Directors

brain tumor quoteI am one of the lucky ones. My brain tumor was discovered in its early stages which absolutely played a role in my survival.-Thomas A. Donovan

Philip E. Stieg Ph.D, M.D., BTF President

Michael Schreiber, BTF Chairman

Patrick J. Kelly, M.D., F.A.C.S., Founding President

Michael Amo

Rhonda Barad

Mary Jo Brown

Thomas A. Donovan

Tammie Gabriel

John Golfinos, M.D.

Chaya Kalcheim, M.D.

Barbara LaVallee

Sandy Markowitz

Faye McCluckie

Jodi Roth

Anthony Scaramucci

Scientific Advisory Board

greybarBTF’s Scientific Advisory Board is an incredible resource and an even greater reservoir of knowledge and guidance for patients and their families.

Armando Basso, M.D., Ph.D., F.A.C.S.

University of Buenos Aires

Professor and Chairman, Department of Neurosurgery
view bio

Mitchel S. Berger, M.D., F.A.C.S. , F.A.A.N.S.

UCSF Department of Neurosurgery

Professor and Chairman, Department of Neurological Surgery
Berthold and Belle N. Guggenhime Endowed Chair
Director  Brain Tumor Surgery Program
Director Neurosurgical Research Centers, Brain Tumor Research Center
view bio

Giovanni Broggi, M.D.

Istituto O.Galeazzi, Milan, Italy

Department of Neurosurgery, Istituto Neurologico Carlo Besta of Milano, Milan and
Department of Neurosurgery
view bio

Jeffrey N. Bruce, M.D., F.A.C.S.

Columbia University Medical Center

Edgar M. Housepian Professor of Neurological Surgery
Vice Chairman of Academic Affairs
Director, Bartoli Brain Tumor Research Laboratory
Co-Director, Brain Tumor Center
view bio

Peter Burger, M.D.

Johns Hopkins Medical Center

Professor of Pathology, Neurosurgery and Oncology
Director of Surgical Neuropathology
view bio

J.P. Chodkiewicz, M.D.

Sainte Anne Hospital, Paris, France

Professor

Catherine Daumas-Duport, M.D.

Sainte Anne Hospital, Paris, France

Neuroscience Oncology and Pathology
view bio

Bernadine Donahue, M.D.

Maimonides Medical Center

Vice Chair & Clinical Director, Radiation Oncology
view bio

Mark R. Gillbert, M.D.

NIH National Cancer Institute

Chief, Neuro-Oncology Branch
Senior Investigator
view bio

John G. Golfinos, M.D., A.B.

NYU Langone Medical Center

Chairman, Department of Neurosurgery
view bio

Tessa Hedley-Whyte, M.D.

Massachusetts General Hospital

Pathologist
view bio

Frederick F. Lang, Jr., M.D., F.A.C.S., F.A.A.N.S.

University of Texas, MD Anderson Cancer Center

Professor (tenure)
Department of Neurosurgery, Division of Surgery
view bio

Edward Laws, M.D.

Brigham and Women’s Hospital

Director, Pituitary and Neuroendocrine Center
view bio

Jay Loeffler, M.D.

Massachusetts General Hospital

Chief, Radiation Oncology
view bio

Robert L. Martuza, M.D., F.A.C.S.

Massachusetts General Hospital

William and Elizabeth Sweet Professor of Neuroscience
Department of Surgery (Neurosurgery)
Harvard Medical School
Chief Neurosurgical Service
Attending Neurosurgeon, Massachusetts General Hospital
view bio

Douglas C. Miller, M.D.

University of Missouri School of Medicine

Clinical Professor of Pathology and Anatomical Sciences
view bio

Alfred Neugut, M.D.

Columbia University Mailman School of Public Health

Myron M. Studner Professor of Cancer Research (In Medicine)
at Columbia University Medical Center
view bio

Christoph Ostertag, M.D.

Albert-Ludwigs-University Freiburg, Germany

Professor of Neurosurgery
Chairman Emeritus
Dept. of Stereotactic and Functional Neurosurgery
view bio

Susan C. Pannullo, M.D.

Weill Cornell Medical Center/Brain and Spine Center

Director of Neuro-oncology and Director of Neurosurgical Radiosurgery
view bio

Jon Robertson, M.D.

University of Tennessee Health Science Center

Chairmanship Emeritus, Department of Neurosurgery
view bio

Jane Roskams, M.D.

Allen Institute for Brain Science

Executive Director
Professor, Departments of Psychiatry and Zoology
view bio

Gail L. Rosseau, M.D.

NorthShore Medical Group

Director, Skull Base Surgery
view bio

Theodore H. Schwartz, M.D.

Weill Cornell Brain and Spine Center

Professor of Neurosurgery, Neurology, and Otolaryngology
Director, Center for Epilepsy and Pituitary Surgery
Co-Director, Surgical Neuro-oncology
view bio

David Thomas, M.D.

Riddle Memorial Hospital, Center for Neuroscience, PA

Campus Chief of Medicine
Chief of Neurology and
Founder/President of The Center for Neuroscience
view bio

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Receive the latest news and updates about Brain Tumor Research and treatments

You have successfully subscriber to Gray Matters, Brain Tumor Foundation's newsletter!

Pin It on Pinterest

Share This